Phosphatidylethanolamine participates in the stimulation of the contact system of coagulation by very-low-density lipoproteins

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 10, 2001, Pages 1695-1700

  Klein, Sonja ^a   Spannagl, Michael ^a   Engelmann, Bernd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Contact pathway; Corn trypsin inhibitor; Factor XII; Phosphatidylethanolamine; Very low density lipoproteins

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 12A; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; THROMBIN; TRYPSIN INHIBITOR; VERY LOW DENSITY LIPOPROTEIN;

AQUEOUS SOLUTION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CONTROLLED STUDY; FIBRIN FORMATION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; LIPID VESICLE; MICROEMULSION; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA;

EID: 0035725961     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/atvb.21.10.1695     Document Type: Article

References (32)

1. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa
2. Risk of coronary heart disease and activation of factor XII in middle-aged men
3. Levels of activated FXII in survivors of myocardial infarction: Association with circulating risk factors and extent of coronary artery disease
4. Activated factor XII levels are dependent on factor XII 46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects
5. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide. A concentration, and risk of coronary heart disease in men
6. Activation of factor VII by Hageman factor fragment
7. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface
8. Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels
9. The interrelationship of factor VII and its activity state with plasma lipids in healthy male adults
10. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway
11. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency
12. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment
13. The normal thrombelastogram and its interpretation
14. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
15. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
16. A rapid method of total lipid extraction and purification
17. Measurement of thrombin generation in whole blood: The effect of heparin and aspirin
18. Structural determinants of the bifunctional corn Hageman factor inhibitor: X-ray crystal structure at 1.95 Å resolution
19. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: Clinical aspects
20. Evidence that triglycerides are an independent coronary heart disease risk factor
21. Lipid composition of lipoproteins in normal and diseased states
22. Cardiolipin is a normal component of human plasma lipoproteins
23. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C
24. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles
25. Platelet agonists enhance the import of phosphatidylethanolamine into human platelets
26. Role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces
27. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies
28. Anti-phosphatidylethanolamine (aPE) antibodies: A survey
29. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: A study in familial lipoprotein-lipase deficiency
30. The activation of the contact phase of coagulation by physiologic surfaces in plasma: The effect of large negatively charged liposomal vesicles
31. The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface
32. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation